Viewing Study NCT00625560


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-03-08 @ 5:55 AM
Study NCT ID: NCT00625560
Status: COMPLETED
Last Update Posted: 2012-05-08
First Post: 2008-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA
Sponsor: Yonsei University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 4-2007-0351
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View